Desq Long
Sign in

Company

IOVANCE BIOTHERAPEUTICS, INC.

IOVA · CIK 0001425205

SEC FORM 4
$0.00

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Acquisition (code M) of 9,766 shares at $0 per share.

Reporting Person Puri Raj K. · Officer Title Chief Regulatory Officer · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106748 · filed 2026-09-10 · View filing →

SEC FORM 4
$38,958.60

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Disposition (code F) of 4,478 shares at $8.70 per share.

Reporting Person Puri Raj K. · Officer Title Chief Regulatory Officer · Transaction Code F

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106748 · filed 2026-09-10 · View filing →

SEC FORM 4
$0.00

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Acquisition (code M) of 7,813 shares at $0 per share.

Reporting Person BILINSKY IGOR · Officer Title Chief Operating Officer · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106750 · filed 2026-09-10 · View filing →

SEC FORM 4
$34,591.20

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Disposition (code F) of 3,976 shares at $8.70 per share.

Reporting Person BILINSKY IGOR · Officer Title Chief Operating Officer · Transaction Code F

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106750 · filed 2026-09-10 · View filing →

SEC FORM 4
$0.00

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Acquisition (code M) of 15,626 shares at $0 per share.

Reporting Person Vogt Frederick G · Officer Title Interim CEO & General Counsel · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106752 · filed 2026-09-10 · View filing →

SEC FORM 4
$57,750.60

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Disposition (code F) of 6,638 shares at $8.70 per share.

Reporting Person Vogt Frederick G · Officer Title Interim CEO & General Counsel · Transaction Code F

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106752 · filed 2026-09-10 · View filing →

SEC FORM 4
$0.00

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Acquisition (code M) of 8,789 shares at $0 per share.

Reporting Person BILINSKY IGOR · Officer Title Chief Operating Officer · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001104659-26-105099 · filed 2026-09-03 · View filing →

SEC FORM 4
$37,028.16

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Disposition (code F) of 4,472 shares at $8.28 per share.

Reporting Person BILINSKY IGOR · Officer Title Chief Operating Officer · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001104659-26-105099 · filed 2026-09-03 · View filing →

SEC FORM 4
$0.00

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Acquisition (code M) of 5,470 shares at $0 per share.

Reporting Person Puri Raj K. · Officer Title Chief Regulatory Officer · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001104659-26-105100 · filed 2026-09-03 · View filing →

SEC FORM 4
$20,766.24

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Disposition (code F) of 2,508 shares at $8.28 per share.

Reporting Person Puri Raj K. · Officer Title Chief Regulatory Officer · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001104659-26-105100 · filed 2026-09-03 · View filing →

SEC FORM 4
$0.00

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Acquisition (code M) of 41,669 shares at $0 per share.

Reporting Person Vogt Frederick G · Officer Title Interim CEO & General Counsel · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001104659-26-105101 · filed 2026-09-03 · View filing →

SEC FORM 4
$146,572.56

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Disposition (code F) of 17,702 shares at $8.28 per share.

Reporting Person Vogt Frederick G · Officer Title Interim CEO & General Counsel · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001104659-26-105101 · filed 2026-09-03 · View filing →

SEC FORM 4
$0.00

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Acquisition (code M) of 10,001 shares at $0 per share.

Reporting Person Kirby Daniel Gordon · Officer Title Chief Commercial Officer · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095040 · filed 2026-08-12 · View filing →

SEC FORM 4
$15,590.40

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Disposition (code F) of 2,436 shares at $6.40 per share.

Reporting Person Kirby Daniel Gordon · Officer Title Chief Commercial Officer · Transaction Code F

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095040 · filed 2026-08-12 · View filing →